Tag: PPIs
-
Acid reflux drugs do not cause cancer after all, study finds
New Study Dismisses Long-Standing Cancer Link to Acid Reflux Drugs For four decades, scientists and clinicians have periodically warned that proton pump inhibitors (PPIs) used to treat acid reflux could be tied to cancer. Omeprazole, lansoprazole and other PPIs are among the most commonly prescribed medicines in Britain, with millions relying on them for relief…
-
New Study Douses Link Between Acid Reflux Drugs and Cancer
Long-Standing Concerns About Acid Reflux Meds For decades, proton pump inhibitors (PPIs) like omeprazole and lansoprazole have been the go-to treatment for heartburn, acid reflux, and ulcers. Yet a persistent fear lingered in public discourse: could these widely prescribed drugs raise cancer risk? A new study aims to settle the debate, providing reassurance to millions…
-
Acid reflux drugs do not cause cancer, study finds: Long‑standing link debunked
New findings ease long‑standing fears about acid reflux medications For decades, concerns about a possible link between proton pump inhibitors (PPIs) and cancer have persisted. These widely used drugs, including omeprazole, esomeprazole, pantoprazole, and lansoprazole, are frontline treatments for gastroesophageal reflux disease (GERD), ulcers, and other digestive conditions. A major new study has found no…
-
NHS Urges Caution: Reassessing Eight-Week Use of Omeprazole and Lansoprazole
What has the NHS said about eight-week PPI use? Health services in the United Kingdom have sounded a clear warning to people who rely on the proton pump inhibitors (PPIs) omeprazole and lansoprazole for digestive issues. The NHS advises patients and prescribers to reassess the need for continued therapy after around eight weeks. While these…